Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case

Coronavirus disease (COVID-19) is often associated with endocrine complications. The article describes a clinical case of the patient with type 2 diabetes mellitus and COVID-19 after which, for the first time, there was a need for basal-bolus insulin therapy, and secondly, a significant arterial hyp...

Full description

Bibliographic Details
Main Authors: N.O. Pertseva, T.V. Chursinova, A.A. Gryshniakova
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2023-04-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
Online Access:https://iej.zaslavsky.com.ua/index.php/journal/article/view/1261
_version_ 1797811190326362112
author N.O. Pertseva
T.V. Chursinova
A.A. Gryshniakova
author_facet N.O. Pertseva
T.V. Chursinova
A.A. Gryshniakova
author_sort N.O. Pertseva
collection DOAJ
description Coronavirus disease (COVID-19) is often associated with endocrine complications. The article describes a clinical case of the patient with type 2 diabetes mellitus and COVID-19 after which, for the first time, there was a need for basal-bolus insulin therapy, and secondly, a significant arterial hypotension occurred. The mechanism of damage to β-cells of the pancreas in the patient is debatable. After analyzing the features of diabetes course, we found an acute onset of the disease at the age of 44 years with pronounced hyperglycemia and ketosis, which required insulin therapy. Then for a long time there was no need in insulin therapy, and the patient took metformin, having overweight, no antibodies to β-cell antigens. It is also impossible to exclude the effect of SARS-CoV-2 on the secretory function of β-cells of the pancreas. Accordingly, clinical cases are interesting, as their analysis helps to understand not only the mecha­nism of development and progression of this infection, but also the diagnosis and treatment of its complications. We have described a rare clinical case of the hyporeninemic hypoaldosteronism in the patient with type 2 diabetes mellitus after COVID-19 infection. A feature of the hyporeninemic hypoaldosteronism course was the absence of electrolyte disorders in the patient, with severe arterial hypotension, suppression of renin and aldosterone. We believe that the hyporeninemic hypoaldosteronism has been associated with the progression of chronic diabetes complications, mainly autonomic neuropathy against the background of COVID-19. To improve the identified disorders, replacement therapy with mineralocorticoids was prescribed. The blood pressure, symptoms of fluid retention and electrolyte levels were monitored when selecting the dose of fludrocortisone. The patient has been under observation for 14 months, the need for fludrocortisone replacement therapy persists to this day. Practicing doctors need to pay attention to the diagnosis of autonomic disorders, which reduce the patients’ quality of life and are an independent risk factor for cardiovascular mortality.
first_indexed 2024-03-13T07:18:59Z
format Article
id doaj.art-498ec6b4760845b2a396121e69fafdb3
institution Directory Open Access Journal
issn 2224-0721
2307-1427
language English
last_indexed 2024-03-13T07:18:59Z
publishDate 2023-04-01
publisher Zaslavsky O.Yu.
record_format Article
series Mìžnarodnij Endokrinologìčnij Žurnal
spelling doaj.art-498ec6b4760845b2a396121e69fafdb32023-06-04T19:53:38ZengZaslavsky O.Yu.Mìžnarodnij Endokrinologìčnij Žurnal2224-07212307-14272023-04-0119214915310.22141/2224-0721.19.2.2023.12611259Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical caseN.O. Pertseva0https://orcid.org/0000-0002-5828-6270T.V. Chursinova1A.A. Gryshniakova2Dnipro State Medical University, Dnipro, UkraineDnipro State Medical University, Dnipro, UkraineSSD “University Clinic” of Dnipro State Medical University, Dnipro, UkraineCoronavirus disease (COVID-19) is often associated with endocrine complications. The article describes a clinical case of the patient with type 2 diabetes mellitus and COVID-19 after which, for the first time, there was a need for basal-bolus insulin therapy, and secondly, a significant arterial hypotension occurred. The mechanism of damage to β-cells of the pancreas in the patient is debatable. After analyzing the features of diabetes course, we found an acute onset of the disease at the age of 44 years with pronounced hyperglycemia and ketosis, which required insulin therapy. Then for a long time there was no need in insulin therapy, and the patient took metformin, having overweight, no antibodies to β-cell antigens. It is also impossible to exclude the effect of SARS-CoV-2 on the secretory function of β-cells of the pancreas. Accordingly, clinical cases are interesting, as their analysis helps to understand not only the mecha­nism of development and progression of this infection, but also the diagnosis and treatment of its complications. We have described a rare clinical case of the hyporeninemic hypoaldosteronism in the patient with type 2 diabetes mellitus after COVID-19 infection. A feature of the hyporeninemic hypoaldosteronism course was the absence of electrolyte disorders in the patient, with severe arterial hypotension, suppression of renin and aldosterone. We believe that the hyporeninemic hypoaldosteronism has been associated with the progression of chronic diabetes complications, mainly autonomic neuropathy against the background of COVID-19. To improve the identified disorders, replacement therapy with mineralocorticoids was prescribed. The blood pressure, symptoms of fluid retention and electrolyte levels were monitored when selecting the dose of fludrocortisone. The patient has been under observation for 14 months, the need for fludrocortisone replacement therapy persists to this day. Practicing doctors need to pay attention to the diagnosis of autonomic disorders, which reduce the patients’ quality of life and are an independent risk factor for cardiovascular mortality.https://iej.zaslavsky.com.ua/index.php/journal/article/view/1261type 2 diabetes mellitushyporeninemic hypoaldosteronismcoronavirus diseaseautonomic neuropathydiagnosis
spellingShingle N.O. Pertseva
T.V. Chursinova
A.A. Gryshniakova
Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
Mìžnarodnij Endokrinologìčnij Žurnal
type 2 diabetes mellitus
hyporeninemic hypoaldosteronism
coronavirus disease
autonomic neuropathy
diagnosis
title Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
title_full Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
title_fullStr Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
title_full_unstemmed Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
title_short Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case
title_sort hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease a clinical case
topic type 2 diabetes mellitus
hyporeninemic hypoaldosteronism
coronavirus disease
autonomic neuropathy
diagnosis
url https://iej.zaslavsky.com.ua/index.php/journal/article/view/1261
work_keys_str_mv AT nopertseva hyporeninemichypoaldosteronismasamanifestationofautonomicneuropathyinapatientwithtype2diabetesmellitusagainstthebackgroundofcoronavirusdiseaseaclinicalcase
AT tvchursinova hyporeninemichypoaldosteronismasamanifestationofautonomicneuropathyinapatientwithtype2diabetesmellitusagainstthebackgroundofcoronavirusdiseaseaclinicalcase
AT aagryshniakova hyporeninemichypoaldosteronismasamanifestationofautonomicneuropathyinapatientwithtype2diabetesmellitusagainstthebackgroundofcoronavirusdiseaseaclinicalcase